Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2005

 

Commission File No. 0-16614

 

NEORX CORPORATION

(Exact name of Registrant as specified in its charter)

 

Washington

 

91-1261311

(State or other jurisdiction of
incorporation or organization)

 

(IRS Employer Identification No.)

 

 

 

300 Elliott Avenue West, Suite 500, Seattle, Washington 98119-4114

(Address of principal executive offices)

 

 

 

Registrant’s telephone number, including area code: (206) 281-7001

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes

ý

 

No

o

 

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act.

 

Yes

ý

 

No

o

 

As of May 6, 2005, 34,228,953 shares of the Registrant’s common stock, $.02 par value per share, were outstanding.

 

 



 

TABLE OF CONTENTS

 

QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2005

 

PART I

FINANCIAL INFORMATION

 

 

 

 

Item 1.

Financial Statements

 

 

 

 

 

Condensed Consolidated Balance Sheets as of March 31, 2005 (unaudited) and December 31, 2004

 

 

 

 

 

Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2005 and 2004 (unaudited)

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2005 and 2004 (unaudited)

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

 

PART II

OTHER INFORMATION

 

 

 

 

Item 6.

Exhibits

 

 

 

 

Signatures

 

 

 

 

 

Exhibit Index

 

 

 

2



 

PART I.  FINANCIAL INFORMATION

 

Item 1.  Financial Statements

 

NEORX CORPORATION AND SUBSIDIARY

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

 

 

 

(unaudited)

 

 

 

 

 

March 31,
2005

 

December 31,
2004

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

16,147

 

$

16,254

 

Investment securities

 

 

1,499

 

Prepaid expenses and other current assets

 

646

 

639

 

Total current assets

 

16,793

 

18,392

 

 

 

 

 

 

 

Facilities and equipment, net

 

6,986

 

7,102

 

Other assets

 

67

 

67

 

Licensed products, net of accumulated amortization of $167 and $125

 

1,833

 

1,875

 

 

 

 

 

 

 

Total assets

 

$

25,679

 

$

27,436

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

539

 

$

1,130

 

Accrued liabilities

 

1,560

 

1,271

 

Current portion of note payable

 

269

 

302

 

Total current liabilities

 

2,368

 

2,703

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

Note payable, net of current portion

 

3,882

 

3,905

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

Preferred stock, $.02 par value, 3,000,000 shares authorized:

 

 

 

 

 

Convertible preferred stock, Series 1, 205,340 shares issued and outstanding at March 31, 2005 and December 31, 2004 (entitled in liquidation to $5,300 and $5,175, respectively)

 

4

 

4

 

Convertible preferred stock, Series B, 1,575 shares issued and outstanding at March 31, 2005 and December 31, 2004 (entitled in liquidation to $15,750)

 

 

 

Common stock, $.02 par value, 60,000,000 shares authorized, 34,228,953 and 30,908,753 shares issued and outstanding at March 31, 2005 and December 31, 2004, respectively

 

685

 

618

 

Additional paid-in capital

 

258,244

 

254,510

 

Accumulated deficit, including other comprehensive loss of $0 and $1 at March 31, 2005 and December 31, 2004, respectively

 

(239,504

)

(234,304

)

Total shareholders’ equity

 

19,429

 

20,828

 

 

 

 

 

 

 

Total liabilities and shareholders’ equity

 

$

25,679

 

$

27,436

 

 

See accompanying notes to the condensed consolidated financial statements.

 

3



 

NEORX CORPORATION AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

(in thousands, except share data)

 

 

 

Three Months Ended March 31,

 

 

 

2005

 

2004

 

 

 

 

 

 

 

Revenues

 

$

 

$

500

 

Operating expenses:

 

 

 

 

 

Research and development

 

3,345

 

3,782

 

General and administrative

 

1,761

 

1,677